TNF and inflammatory bowel disease: Anti-inflammatory drugs, such as 5-aminosalicylic acid (5-ASA) or anti-TNF-α agents, such as infliximab and adalimumab, have been used in the treatment of other inflammatory conditions, such as inflammatory bowel disease (IBD).